Phytopharm PLC
25 August 2000
Disclosure of Shareholding
Following the exercise of a total of 111,500 options to purchase Phytopharm
ordinary shares at 192.5p on 25 August 2000, Richard Dixey, Chief Executive of
Phytopharm has now increased his shareholding and is the beneficial owner of
8,043,500 ordinary shares in Phytopharm plc, representing 22.25% of the total
issued share capital of the Company.
Dr R P Dixey's ownership arises from the exercise of the option and his
holding of 50% of the share capital of Chakra Ltd, which owns 7,932,000 shares
in Phytopharm plc.
Enquiries:
Phytopharm plc Tel: 01480 437697
Dr Richard Dixey Chief Executive
Dr Simon Loach Chief Financial Officer
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.